Loading...

The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective κ-opioid receptor agonist, enadoline, in the monoamine-depleted rat

1. The treatment of Parkinson's disease relies predominantly upon dopamine replacement therapy, usually with l-dihydroxyphenylalanine (L-DOPA). However, side-effects of long-term treatment, such as L-DOPA-induced dyskinesias can be more debilitating than the disease itself. Non-dopaminergic tre...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Hill, M P, Brotchie, J M
Format: Artigo
Sprog:Inglês
Udgivet: 1999
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1571785/
https://ncbi.nlm.nih.gov/pubmed/10602339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0702943
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!